Abstract:Ferroptosis, a unique modality of cell death with mechanistic and morphological differences from other cell death modes, plays a pivotal role in regulating tumorigenesis and offers a new opportunity for modulating anticancer drug resistance. Aberrant epigenetic modifications and posttranslational modifications (PTMs) promote anticancer drug resistance, cancer progression, and metastasis. Accumulating studies indicate that epigenetic modifications can transcriptionally and translationally determine cancer cell vulnerability to ferroptosis and that ferroptosis functions as a driver in nervous system diseases (NSDs), cardiovascular diseases (CVDs), liver diseases, lung diseases, and kidney diseases. In this review, we first summarize the core molecular mechanisms of ferroptosis. Then, the roles of epigenetic processes, including histone PTMs, DNA methylation, and noncoding RNA regulation and PTMs, such as phosphorylation, ubiquitination, SUMOylation, acetylation, methylation, and ADP-ribosylation, are concisely discussed. The roles of epigenetic modifications and PTMs in ferroptosis regulation in the genesis of diseases, including cancers, NSD, CVDs, liver diseases, lung diseases, and kidney diseases, as well as the application of epigenetic and PTM modulators in the therapy of these diseases, are then discussed in detail. Elucidating the mechanisms of ferroptosis regulation mediated by epigenetic modifications and PTMs in cancer and other diseases will facilitate the development of promising combination therapeutic regimens containing epigenetic or PTM-targeting agents and ferroptosis inducers that can be used to overcome chemotherapeutic resistance in cancer and could be used to prevent other diseases. In addition, these mechanisms highlight potential therapeutic approaches to overcome chemoresistance in cancer or halt the genesis of other diseases.

Epigenetic Regulation of Ferroptosis-Associated Genes and Its Implication in Cancer Therapy

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis Regulation by Methylation in Cancer

Insights into the Roles of Epigenetic Modifications in Ferroptosis

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases

The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression

Ferroptosis and its emerging role in tumor

Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases

Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis

Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach

Ferroptosis: A double-edged sword

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors

Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance

Ferroptosis in life: To be or not to be

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance

Molecular mechanisms of ferroptosis and its role in cancer therapy

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

The function and mechanism of ferroptosis in cancer

Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor